Race and prostate imaging: implications for targeted biopsy and image-based prostate cancer interventions.

For men with an elevated prostate-specific antigen (PSA), there is a strong evidence for prostate MRI to assess the risk of clinically significant prostate cancer (CSPC) and guide targeted-biopsy interventions.